Free Trial

Life Science REIT (LON:LABS) Stock Price Up 0.5% - Here's Why

Life Science REIT logo with Real Estate background

Key Points

  • Life Science REIT plc (LON:LABS) saw a stock price increase of 0.5%, trading at GBX 38 ($0.51) after previously closing at GBX 37.80 ($0.51).
  • The company has a market capitalization of £134.91 million, with a P/E ratio of -3.37 and low trading volume of about 268,118 shares compared to an average of 747,950 shares.
  • Life Science REIT plc is a closed-ended Real Estate Investment Trust that started trading on the London Stock Exchange on November 19, 2021.
  • Five stocks we like better than Life Science REIT.

Life Science REIT plc (LON:LABS - Get Free Report)'s stock price was up 0.5% during mid-day trading on Tuesday . The company traded as high as GBX 38.30 ($0.52) and last traded at GBX 38 ($0.51). Approximately 268,118 shares were traded during mid-day trading, a decline of 64% from the average daily volume of 747,950 shares. The stock had previously closed at GBX 37.80 ($0.51).

Life Science REIT Stock Performance

The business's 50 day moving average is GBX 41.74 and its 200-day moving average is GBX 41.35. The firm has a market capitalization of £136.33 million, a price-to-earnings ratio of -3.40 and a beta of 0.08.

About Life Science REIT

(Get Free Report)

Life Science REIT plc (the Company) is a closed-ended Real Estate Investment Trust (REIT) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange.

Further Reading

Should You Invest $1,000 in Life Science REIT Right Now?

Before you consider Life Science REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Life Science REIT wasn't on the list.

While Life Science REIT currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.